HIM
SWTX

HGC Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History

HGC Investment Management’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48,443
Closed -$2.28M – 139
2025
Q2 		$2.28M Buy
+48,443
New +$2.16M 0.63% 50

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HGC Investment Management's SWTX Position: Q3 2025 in Review

HGC Investment Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 48,443 shares — an estimated $2.28M sold.

HGC Investment Management first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $2.28M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • HGC Investment Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • HGC Investment Management sold 48,443 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.28M.
  • HGC Investment Management first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
  • HGC Investment Management's SpringWorks Therapeutics position peaked at $2.28M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on HGC Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.